CompletedPhase 2NCT01856933

BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)

Studying Gliosarcoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Heinrich Elinzano, MD
Principal Investigator
Heinrich Elinzano, MD, MD
Brown University
Intervention
PSMA ADC(drug)
Enrollment
6 enrolled
Eligibility
18 years · All sexes
Timeline
2013 – 2015

Study locations (2)

Collaborators

Progenics Pharmaceuticals, Inc. · Rhode Island Hospital · University of Texas

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01856933 on ClinicalTrials.gov

Other trials for Gliosarcoma

Additional recruiting or active studies for the same condition.

See all trials for Gliosarcoma →

← Back to all trials